$AVGO

Brazeal Mark David sold $9.5M of AVGO

Brazeal Mark David (Chief Legal & Corp Affairs Ofc) sold 25,000 shares of Broadcom Inc. (AVGO) at $379.19 ($9.48M total) on 2026-07-08.

Original reporting
SEC EDGAR · Brazeal Mark David
Published Jul 10, 2026, 10:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 10, 2026, 10:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AVGO
Neutral
medium confidence
Mentioned
$AVGO
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AVGONeutralLow
01

Why it matters

A single officer open-market sale of $9.48M is more relevant for short-term sentiment than for long-term valuation, absent any accompanying fundamental news.

02

Market read

Traders may monitor for follow-on insider activity, but there is no new operational or financial catalyst in the text.

03

What to watch

No 10b5-1 plan is stated, but insider sales can still be pre-planned under other arrangements; the filing provides no reason for the sale or any follow-on buying.

Relevance 6/10Novelty 5/10Timing: Filed 2026-07-10 after the 2026-07-08 sale date.

Background

The article is an SEC Form 4 insider transaction disclosure for Broadcom Inc.

Company-level read

Ticker impact

$AVGONeutralMedium confidence
Context

Broadcom Form 4 shows officer Brazeal Mark David sold 25,000 shares on 2026-07-08 at $379.1880 for about $9.48M.

Expected impact

Likely limited near-term impact; any effect is more sentiment-driven than thesis-changing.

Evidence & confidence

The filing is primary-source and time-stamped, but it does not disclose new company fundamentals, guidance, or transactions beyond the sale size and price.

Market effects

Minimal; insider sales in a mega-cap typically do not reset sector fundamentals.

None indicated.

None indicated.

Counterpoint

The sale may be routine liquidity or diversification, especially since the filing does not indicate any adverse company event.

Key entities

  • Broadcom Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Brazeal Mark David

    Chief Legal & Corporate Affairs Officer who sold 25,000 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AVGOMed

Anthropic Revenue Jumps 47% but Swings to Loss on AI Infrastructure

Anthropic reported a 47% revenue increase to $16.962 billion but swung to a $567 million operating loss. The AI company, preparing for an IPO, has committed $895.4 billion to AI infrastructure, with Broadcom, Google Cloud, SpaceXAI, and AWS as key suppliers. SK hynix is considering DRAM production in Ohio, while LG Energy Solution saw a 25.7% rise in Q3 operating profit.

$AAPLMed

Stock Market Today: Nasdaq Rises Despite Apple Slump as Investors Watch Midterms, Gold Gains +0.19%

U.S. tech stocks rebounded on Nov 3, with the Nasdaq up 0.9% and S&P 500 up 0.4%, driven by semiconductor gains. Nvidia and Broadcom rose 2.3% and 3.1%, respectively, while Apple fell 1.9%. AMD reported $13.4B in revenue, beating expectations. Palantir dropped 1.6% despite 96% revenue growth. Oil prices rose due to Middle East tensions. Gold and silver saw minor gains. Investors watched U.S. midterm elections.

$MRVLHighAI 9/10

Marvell’s Lumentum Buy Threatens Broadcom’s AI Optics Lead, Says TrendForce

Marvell (MRVL) announced an all-stock acquisition of Lumentum (LITE), approved by both boards. TrendForce says the combined entity could challenge Broadcom's (AVGO) lead in AI optical communications, with a potential 7% revenue share in the semiconductor wired communications market. The deal may reduce cloud providers' reliance on Broadcom and position Marvell for next-gen optical interconnects. China's review may focus on potential market restrictions.

$AVGOMed

Why is Broadcom stock rallying today?

Broadcom (AVGO) stock rose 3.3% to $332.81 after a $63B chip financing deal with banks, supporting AI infrastructure. The company backstops $43.5B of senior debt. Analysts maintain a 'Strong Buy' rating, citing demand strength. The Nasdaq and S&P 500 also gained, overshadowing Fed rate hike concerns.